MOGAD与NMOSD、MS及健康对照的纵向脑容量MRI比较及残疾关联
本研究纳入32例MOGAD、160例MS、49例NMOSD和52例健康对照,采用标准化容积MRI比较纵向脑容量变化。MOGAD所有脑区体积丢失速率均快于健康对照,深部灰质较MS保留更好,但纵向侧脑室分数增加,且容量丢失与残疾相关。
要点
- MOGAD所有脑区体积丢失速率均快于健康对照(p<0.05)。
- MOGAD基线丘脑、尾状核和壳核分数较MS保留更好。
- MOGAD纵向侧脑室分数增加,但海马和上颈髓面积丢失较NMOSD少。
核心结论
- MOGAD纵向脑容量丢失快于健康对照,深部灰质较MS相对保留,但容量丢失与残疾相关。
研究设计与样本
- 混合线性模型比较标准化容积MRI,MOGAD与年龄、性别和病程匹配的MS(5:1)及非匹配NMOSD和健康对照。
- 共纳入293例患者:32例MOGAD、160例MS、49例NMOSD和52例健康对照。
主要发现
- MOGAD所有脑区体积丢失速率均快于健康对照(p<0.05)。
- 基线时MOGAD丘脑分数(0.000507,p=0.005)、尾状核分数(0.000287,p=0.004)和壳核分数(0.000341,p=0.007)较MS保留更好。
- 纵向比较,MOGAD侧脑室分数增加(-0.000645,p=0.032),但海马(0.000031,p=0.044)和上颈髓面积(1.482887,p=0.005)丢失较NMOSD少。
- 纵向比较,MOGAD侧脑室分数增加(0.00529,p<0.001),但上颈髓面积丢失较MS少(0.538656,p=0.042)。
- MOGAD中上颈髓面积与PDDS(-0.72,p=0.004)和CST(0.60,p=0.014)相关,全脑分数与PDDS(-0.66,p=0.01)和PST(0.52,p=0.019)相关,侧脑室分数与PDDS(0.78,p<0.001)相关。
临床怎么用
- 容积MRI可显示MOGAD脑区萎缩模式,深部灰质相对保留有助于与MS鉴别。
- MOGAD患者上颈髓面积和侧脑室分数等容量指标与残疾评分相关,可用于监测疾病进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine volumetric magnetic resonance imaging (vMRI) in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), compared to multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and healthy controls (HC). METHODS: Standardized vMRI in MOGAD were compared to age, sex, and disease duration matched MS (5:1), and non-matched NMOSD and HC, in mixed linear models with time and group interactions. Disability assessments included; patient determined disease steps (PDDS), manual dexterity (MDT), walking speed (WST), processing speed (PST), and contrast sensitivity tests (CST). Correlations between vMRI and disability in MOGAD were examined. RESULTS: A total of 293 patients were included; 32 MOGAD, 160 MS, 49 NMOSD, and 52 HC. MOGAD had a faster rate of volume loss in all brain regions compared to HC (p < 0.05). At baseline, MOGAD had preserved thalamic (0.000507, p = 0.005), caudate (0.000287, p = 0.004), and putamen (0.000341, p = 0.007) fractions than MS. Longitudinally, MOGAD had increased lateral ventricle fraction (LVF) (-0.000645, p = 0.032), but less hippocampal (0.000031, p = 0.044) and upper cervical cord area (UCCA) loss (1.482887, p = 0.005), compared to NMOSD. MOGAD had increased LVF (0.00529, p < 0.001), but less UCCA loss (0.538656, p = 0.042) longitudinally compared to MS. Among MOGAD, UCCA was associated with PDDS (-0.72, p = 0.004) and CST (0.60, p = 0.014). Whole brain fraction (WBF) was associated with PDDS (-0.66, p = 0.01) and PST (0.52, p = 0.019). LVF was associated with PDDS (0.78, p < 0.001). INTERPRETATION: MOGAD showed longitudinal brain volume loss compared to HC. Deep gray matter was relatively preserved compared to MS, while MS and NMOSD had greater UCCA loss, indicating regional differences in atrophy. Despite less overall atrophy, volume loss in MOGAD was associated with disability. ANN NEUROL 2025;98:1044-1056.
引用
- Kunchok A, Amin M, Ongphichetmetha T, et al. Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations. Ann Neurol. 2025. PMID: 40728073. doi:10.1002/ana.27309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。